科匯股份(688681.SH):公司儲能產品主要面向用户側
格隆匯5月13日丨科匯股份(688681.SH)近日在接待投資者調研時表示,公司儲能產品主要面向用户側,根據尋熵研究院統計分析,2023年我國新增新型儲能項目應用裝機中,電源側佔比37.7%,電網側佔比52.6%,用户側佔比僅為9.7%。公司將持續加大研發和市場推廣力度,堅定不移推進電力儲能業務的發展,突出用户側儲能技術優勢,進一步優化提升能量管理雲主站和智慧能量控制器算法,提高用户側儲能收益,結合產品銷售與光儲一體化電站建設,探索並形成儲能業務的盈利模式,培育新的業務增長點,快速實現業務的規模化應用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.